Sponsor

Integra LifeSciences Corporation

Clinical research sponsor

Published trials25

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

25 shown

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg UlcersNCT06453187 · lead sponsor · 2024-11-18

ENROLLING_BY_INVITATION

Post Market Clinical Follow-up of CODMAN CERTAS Programmable ValveNCT05397106 · lead sponsor · 2023-01-24

ACTIVE_NOT_RECRUITING

AmnioExcel® Plus vs SOC in the Management of Diabetic Foot UlcersNCT05024656 · lead sponsor · 2021-09-01

WITHDRAWN

CERTAS Programmable Valve RegistryNCT04207229 · lead sponsor · 2019-11-21

COMPLETED

Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of CareNCT03626623 · lead sponsor · 2019-05-21

TERMINATED

AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot UlcersNCT03547635 · lead sponsor · 2018-05-03

COMPLETED

PriMatrix for the Management of Diabetic Foot UlcersNCT03010319 · lead sponsor · 2017-01-01

COMPLETED

SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy RadiotherapyNCT01959867 · lead sponsor · 2017-01-01

WITHDRAWN

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic UseNCT01840085 · lead sponsor · 2015-12-01

TERMINATED

Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot UlcersNCT02209051 · lead sponsor · 2014-07-01

COMPLETED

A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot UlcersNCT01858545 · lead sponsor · 2013-05-01

TERMINATED

Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot UlcersNCT01849965 · lead sponsor · 2013-04-01

TERMINATED

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot UlcersNCT01830348 · lead sponsor · 2013-02-01

TERMINATED

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrixNCT01729286 · lead sponsor · 2012-09-01

TERMINATED

A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot UlcersNCT01270633 · lead sponsor · 2010-12-01

TERMINATED

The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded TrialNCT01228500 · lead sponsor · 2008-01-01

WITHDRAWN

Intracranial PrEssure Time dOse (ImPETO)NCT04459806 · collaborator · 2023-11-13

RECRUITING

Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical ProstatectomyNCT05842057 · collaborator · 2023-08-24

ACTIVE_NOT_RECRUITING

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical ProstatectomyNCT05363644 · collaborator · 2023-04-01

WITHDRAWN

Characterization of AmnioExcel Plus in Two Treatment ParadigmsNCT04233580 · collaborator · 2020-07-09

COMPLETED

Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic TissueNCT02632929 · collaborator · 2015-05-30

COMPLETED

Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)NCT02557906 · collaborator · 2014-07-01

UNKNOWN

MediHoney for Radiation DermatitisNCT02234479 · collaborator · 2014-06-01

COMPLETED

Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot UlcersNCT01108263 · collaborator · 2010-06-01

TERMINATED

Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic UlcersNCT00796744 · collaborator · 2008-10-01

COMPLETED

Sponsor roles

lead sponsor16

collaborator9

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.